Spark BATIRNCT06378281
Testing a New Method to Improve Informed Consent in Prison Research
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 5 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Minor Trial completed
- Primary and study completion dates changed from estimate of Oct 31, 2026 to Oct 28, 2026
- Site details revised at 2 of 2 sites
- Minor Primary and study completion pushed from Sep 30, 2026 to Oct 31, 2026
- Secondary endpoints: details revised at 2 of 2 entries
- Study description revised
- Eligibility criteria expanded, about 5 words
- Notable Primary and study completion dates pushed to Sep 30, 2026
- Collaborators: 4 to 5
- Notable Trial status: Not Yet Recruiting to Recruiting
- Study sites: 1 to 2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (2)
Arms and interventions
According to ethical requirements of Swiss Human Research Act, the interviewer will explain the nature of the study, its purposes, duration, the potential risks and benefits it entails, and study procedures. He will inform that study participation is voluntary and that participants may withdraw at any time. He will also explain that the study is independent from the prison authorities. Participants will then be given time to read the informed consent, or, if they are not able to read, it will be read to them by the interviewer. The interviewer will answer all questions.
The standard process will first be used. After that, the interviewer will ask participants to summarize the content of the informed consent. The interviewer will correct not-well understood components and ask questions about forgotten components. In case of misconceptions, the participant will be asked to summarize again the corresponding components. A list of key components to be addressed will be developed by study team members, including experts in prison research and ethics, based on components listed in Art. 16 of the Swiss Human Research Act. The material of the informed consent of the parent-randomized controlled trial will be used.
Other: Modified teach-to-goal informed consent
Sites
2 sites in 1 country